Klaus Breiner is the Managing Partner and Co-founder of Pureos Bioventures, a Swiss venture capital firm focused on innovative drug development. With a Ph. D. from Heidelberg University, he has co-founded multiple biotech companies, including Vaximm AG, and serves on the boards of several portfolio companies.
He has a strong international academic background, having studied at both Heidelberg University in Germany and The University of North Carolina at Chapel Hill in the US. His work is driven by a focus on developing treatments for severe diseases through strategic investments.
His firms portfolio company, Araris Biotech, was recently part of one of the largest pre-clinical oncology transactions in history.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.